New Insights Into the Role of Ubiquitylation of Proteins

International Review of Cell and Molecular Biology

Volumn 325, Issue , 2016, Pages 35-88

  McDowell, G S ^a   Philpott, A ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Mass spectrometry; Posttranslational modification; Protein degradation; Ubiquitin like modifications; Ubiquitination; Ubiquitylation

Indexed keywords

CYSTEINE; HECT E3 LIGASE; LYSINE; POLYUBIQUITIN; PROTEIN; RING E3 LIGASE; SERINE; THIOESTER; THREONINE; UBIQUITIN; UBIQUITIN ACTIVATING E1 ENZYME; UBIQUITIN CONJUGATING E2 ENZYME; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOINFORMATICS; CELLULAR DISTRIBUTION; HUMAN; MASS SPECTROMETRY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; UBIQUITINATION; ANIMAL; BIOLOGICAL MODEL; METABOLISM;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; UBIQUITIN; UBIQUITINATION;

EID: 84960977660     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.02.002     Document Type: Chapter

References (310)

1. Abu Hatoum O., Gross-Mesilaty S., Breitschopf K., Hoffman A., Gonen H., Ciechanover A., Bengal E. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol. Cell. Biol. 1998, 18(10):5670-5677.
2. Aguado-Llera D., Goormaghtigh E., de Geest N., Quan X.J., Prieto A., Hassan B.A., Gómez J., Neira J.L. The basic helix-loop-helix region of human neurogenin 1 is a monomeric natively unfolded protein which forms a "fuzzy" complex upon DNA binding. Biochemistry 2010, 49(8):1577-1589.
3. Aksnes H., Hole K., Arnesen T. Molecular, cellular, and physiological significance of N-terminal acetylation. Int. Rev. Cell Mol. Biol. 2015, 316:267-305.
4. Ali F., Hindley C., McDowell G., Deibler R., Jones A., Kirschner M., Guillemot F., Philpott A. Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Development 2011, 138(19):4267-4277.
5. Amerik A.Y., Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 2004, 1695(1-3):189-207.
6. Aravind L., Koonin E.V. The U box is a modified RING finger-a common domain in ubiquitination. Curr. Biol. 2000, 10(4):R132-R134.
7. Aufderheide A., Unverdorben P., Baumeister W., Förster F. Structural disorder and its role in proteasomal degradation. FEBS Lett. 2015, 589:2552-2560.
8. Aviel S., Winberg G., Massucci M., Ciechanover A. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 2000, 275(31):23491-23499.
9. Baker R.T., Tobias J.W., Varshavsky A. Ubiquitin-specific proteases of Saccharomyces cerevisiae. Cloning of UBP2 and UBP3, and functional analysis of the UBP gene family. J. Biol. Chem. 1992, 267(32):23364-23375.
10. Baldi L., Brown K., Franzoso G., Siebenlist U. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha. J. Biol. Chem. 1996, 271(1):376-379.
11. Bashir T., Dorrello N.V., Amador V., Guardavaccaro D., Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004, 428(6979):190-193.
12. Bassermann F., Frescas D., Guardavaccaro D., Busino L., Peschiaroli A., Pagano M. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 2008, 134(2):256-267.
13. Beal R.E., Toscano-Cantaffa D., Young P., Rechsteiner M., Pickart C.M. The hydrophobic effect contributes to polyubiquitin chain recognition. Biochemistry 1998, 37(9):2925-2934.
14. Ben-Nissan G., Sharon M. Regulating the 20S proteasome ubiquitin-independent degradation pathway. Biomolecules 2014, 4(3):862-884.
15. Ben-Saadon R., Fajerman I., Ziv T., Hellman U., Schwartz A.L., Ciechanover A. The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue. J. Biol. Chem. 2004, 279(40):41414-41421.
16. Berleth E.S., Pickart C.M. Mechanism of ubiquitin conjugating enzyme E2-230K: catalysis involving a thiol relay?. Biochemistry 1996, 35(5):1664-1671.
17. Berndsen C.E., Wolberger C. New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol. 2014, 21(4):301-307.
18. Bertrand N., Castro D.S., Guillemot F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 2002, 3(7):517-530.
19. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003, 115(1):71-82. Available from: http://ac.els-cdn.com/S0092867403007554/1-s2.0-S0092867403007554-main.pdf?_tid=8a94a4e8-3938-11e5-96a0-00000aacb362&acdnat=1438535251_51896dc294630b7874c61fada69e566c.
20. Bornstein G., Bloom J., Sitry-Shevah D., Nakayama K., Pagano M., Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 2003, 278(28):25752-25757.
21. Bradshaw R.A., Brickey W.W., Walker K.W. N-terminal processing: the methionine aminopeptidase and N alpha-acetyl transferase families. Trends Biochem. Sci. 1998, 23(7):263-267.
22. Braun B.C., Glickman M., Kraft R., Dahlmann B., Kloetzel P.M., Finley D., Schmidt M. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1999, 1(4):221-226.
23. Breitschopf K., Bengal E., Ziv T., Admon A., Ciechanover A. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 1998, 17(20):5964-5973.
24. Cadwell K., Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005, 309(5731):127-130.
25. Cadwell K., Coscoy L. The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J. Virol. 2008, 82(8):4184-4189.
26. Cai Y., Huang T., Hu L., Shi X., Xie L., Li Y. Prediction of lysine ubiquitination with mRMR feature selection and analysis. Amino Acids 2012, 42(4):1387-1395.
27. Cane D.E., Walsh C.T. The parallel and convergent universes of polyketide synthases and nonribosomal peptide synthetases. Chem. Biol. 1999, 6(12):R319-R325.
28. Cannon J.R., Martinez-Fonts K., Robotham S.A., Matouschek A., Brodbelt J.S. Top-down 193-nm ultraviolet photodissociation mass spectrometry for simultaneous determination of polyubiquitin chain length and topology. Anal. Chem. 2015, 87(3):1812-1820. Available from: http://pubs.acs.org/doi/abs/10.1021/ac5038363.
29. Carvalho A.F., Pinto M.P., Grou C.P., Alencastre I.S., Fransen M., Sá-Miranda C., Azevedo J.E. Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J. Biol. Chem. 2007, 282(43):31267-31272.
30. Chang L., Zhang Z., Yang J., McLaughlin S.H., Barford D. Atomic structure of the APC/C and its mechanism of protein ubiquitination. Nature 2015, 522(7557):450-454.
31. Chaudhuri R., Sadrieh A., Hoffman N.J., Parker B.L., Humphrey S.J., Stöckli J., Hill A.P., James D.E., Yang J.Y. PhosphOrtholog: a web-based tool for cross-species mapping of orthologous protein post-translational modifications. BMC Genomics 2015, 16(1):617.
32. Chiu Y.H., Sun Q., Chen Z.J. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 2007, 27(6):1014-1023.
33. Chu I., Sun J., Arnaout A., Kahn H., Hanna W., Narod S., Sun P., Tan C.K., Hengst L., Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007, 128(2):281-294.
34. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and on to human diseases and drug targeting. Angew. Chem. Int. Ed. Engl. 2004, 44:5944-5967.
35. Ciechanover A. The unravelling of the ubiquitin system. Nat. Rev. Mol. Cell Biol. 2015, 16(5):322-324.
36. Ciechanover A., Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 2004, 14(3):103-106.
37. Ciechanover A., Heller H., Katz-Etzion R., Hershko A. Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system. Proc. Natl. Acad. Sci. USA 1981, 78(2):761-765.
38. Ciechanover A., Stanhill A. The complexity of recognition of ubiquitinated substrates by the 26S proteasome. Biochim. Biophys. Acta 2014, 1843(1):86-96.
39. Ciehanover A., Hod Y., Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. Commun. 1978, 81(4):1100-1105.
40. Clague M.J., Heride C., Urbé S. The demographics of the ubiquitin system. Trends Cell Biol. 2015, 25(7):417-426.
41. Clague M.J., Liu H., Urbé S. Governance of endocytic trafficking and signaling by reversible ubiquitylation. Dev. Cell 2012, 23(3):457-467.
42. Cohen I., Wiener R., Reiss Y., Ravid T. Distinct activation of an E2 ubiquitin-conjugating enzyme by its cognate E3 ligases. Proc. Natl. Acad. Sci. USA 2015, 112(7):E625-E632.
43. Cook W.J., Jeffrey L.C., Carson M., Chen Z., Pickart C.M. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J. Biol. Chem. 1992, 267(23):16467-16471.
44. Coster G., Hayouka Z., Argaman L., Strauss C., Friedler A., Brandeis M., Goldberg M. The DNA damage response mediator MDC1 directly interacts with the anaphase-promoting complex/cyclosome. J. Biol. Chem. 2007, 282(44):32053-32064.
45. Coulombe P., Rodier G., Bonneil E., Thibault P., Meloche S. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 2004, 24(14):6140-6150.
46. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996, 65:801-847.
47. Dantuma N.P., Lindsten K., Glas R., Jellne M., Masucci M.G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 2000, 18(5):538-543.
48. David Y., Ternette N., Edelmann M.J., Ziv T., Gayer B., Sertchook R., Dadon Y., Kessler B.M., Navon A. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J. Biol. Chem. 2011, 286(51):44104-44115.
49. David Y., Ziv T., Admon A., Navon A. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J. Biol. Chem. 2010, 285(12):8595-8604.
50. Debelyy M.O., Platta H.W., Saffian D., Hensel A., Thoms S., Meyer H.E., Warscheid B., Girzalsky W., Erdmann R. Ubp15p, a ubiquitin hydrolase associated with the peroxisomal export machinery. J. Biol. Chem. 2011, 286(32):28223-28234.
51. Dubiel D., Rockel B., Naumann M., Dubiel W. Diversity of COP9 signalosome structures and functional consequences. FEBS Lett. 2015, 589(19A):2507-2513.
52. Dunker A., Lawson J., Brown C., Williams R., Romero P., Oh J., Oldfield C., Campen A., Ratliff C., Hipps K., Ausio J., Nissen M., Reeves R., Kang C., Kissinger C., Bailey R., Griswold M., Chiu W., Garner E., Obradovic Z. Intrinsically disordered protein. J. Mol. Graph. Model. 2001, 19(1):26-59.
53. Dunker A.K., Oldfield C.J., Meng J., Romero P., Yang J.Y., Chen J.W., Vacic V., Obradovic Z., Uversky V.N. The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 2008, 9(Suppl. 2):S1.
54. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6(3):197-208.
55. Dyson H.J., Wright P.E. According to current textbooks, a well-defined three-dimensional structure is a prerequisite for the function of a protein. Is this correct?. IUBMB Life 2006, 58(2):107-109.
56. Eckhart W., Hutchinson M.A., Hunter T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 1979, 18(4):925-933.
57. Ekkebus R., van Kasteren S.I., Kulathu Y., Scholten A., Berlin I., Geurink P.P., de Jong A., Goerdayal S., Neefjes J., Heck A.J., Komander D., Ovaa H. On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J. Am. Chem. Soc. 2013, 135(8):2867-2870.
58. Eletr Z.M., Wilkinson K.D. Regulation of proteolysis by human deubiquitinating enzymes. Biochim. Biophys. Acta 2014, 1843(1):114-128.
59. Erales J., Coffino P. Ubiquitin-independent proteasomal degradation. Biochim. Biophys. Acta 2013, 1843(1):216-221.
60. Faggiano S., Menon R.P., Kelly G.P., Todi S.V., Scaglione K.M., Konarev P.V., Svergun D.I., Paulson H.L., Pastore A. Allosteric regulation of deubiquitylase activity through ubiquitination. Front Mol. Biosci. 2015, 2:2.
61. Fajerman I., Schwartz A.L., Ciechanover A. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem. Biophys. Res. Commun. 2004, 314(2):505-512.
62. Fang S., Weissman A.M. A field guide to ubiquitylation. Cell. Mol. Life Sci. 2004, 61(13):1546-1561.
63. Fersht A.R. Transition-state structure as a unifying basis in protein-folding mechanisms: contact order, chain topology, stability, and the extended nucleus mechanism. Proc. Natl. Acad. Sci. USA 2000, 97(4):1525-1529.
64. Fiesel F.C., Caulfield T.R., Moussaud-Lamodière E.L., Ogaki K., Dourado D.F., Flores S.C., Ross O.A., Springer W. Structural and functional impact of Parkinson disease-associated mutations in the E3 ubiquitin ligase Parkin. Hum. Mutat. 2015, 36(8):774-786.
65. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009, 78:477-513.
66. Fishbain S., Inobe T., Israeli E., Chavali S., Yu H., Kago G., Babu M.M., Matouschek A. Sequence composition of disordered regions fine-tunes protein half-life. Nat. Struct. Mol. Biol. 2015, 22(3):214-221.
67. Fletcher A.J., Christensen D.E., Nelson C., Tan C.P., Schaller T., Lehner P.J., Sundquist W.I., Towers G.J. TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J. 2015, 34:2078-2095.
68. Fletcher A.J., Mallery D.L., Watkinson R.E., Dickson C.F., James L.C. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc. Natl. Acad. Sci. USA 2015, 112:10014-10019.
69. Folin O. A theory of protein metabolism. J. Am. Physiol. 1905, 13:117-138.
70. Fort P., Kajava A.V., Delsuc F., Coux O. Evolution of proteasome regulators in eukaryotes. Genome Biol. Evol. 2015, 7(5):1363-1379.
71. Freiman R.N., Tjian R. Regulating the regulators: lysine modifications make their mark. Cell 2003, 112(1):11-17.
72. García-Higuera I., Manchado E., Dubus P., Cañamero M., Méndez J., Moreno S., Malumbres M. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 2008, 10(7):802-811.
73. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82(2):373-428.
74. Glickman M.H., Rubin D.M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V.A., Finley D. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 1998, 94(5):615-623.
75. Grimmler M., Wang Y., Mund T., Cilensek Z., Keidel E.M., Waddell M.B., Jäkel H., Kullmann M., Kriwacki R.W., Hengst L. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007, 128(2):269-280.
76. Grossman S.R., Deato M.E., Brignone C., Chan H.M., Kung A.L., Tagami H., Nakatani Y., Livingston D.M. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 2003, 300(5617):342-344.
77. Grou C.P., Carvalho A.F., Pinto M.P., Huybrechts S.J., Sá-Miranda C., Fransen M., Azevedo J.E. Properties of the ubiquitin-pex5p thiol ester conjugate. J. Biol. Chem. 2009, 284(16):10504-10513.
78. Grou C.P., Carvalho A.F., Pinto M.P., Wiese S., Piechura H., Meyer H.E., Warscheid B., Sá-Miranda C., Azevedo J.E. Members of the E2D (UbcH5) family mediate the ubiquitination of the conserved cysteine of Pex5p, the peroxisomal import receptor. J. Biol. Chem. 2008, 283(21):14190-14197.
79. Grou C.P., Francisco T., Rodrigues T.A., Freitas M.O., Pinto M.P., Carvalho A.F., Domingues P., Wood S.A., Rodríguez-Borges J.E., Sá-Miranda C., Fransen M., Azevedo J.E. Identification of ubiquitin-specific protease 9X (USP9X) as a deubiquitinase acting on ubiquitin-peroxin 5 (PEX5) thioester conjugate. J. Biol. Chem. 2012, 287(16):12815-12827.
80. Gsponer J., Futschik M.E., Teichmann S.A., Babu M.M. Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 2008, 322(5906):1365-1368.
81. Gu G., Dubauskaite J., Melton D.A. Direct evidence for the pancreatic lineage: NGN3 + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129(10):2447-2457.
82. Hagai T., Levy Y. Ubiquitin not only serves as a tag but also assists degradation by inducing protein unfolding. Proc. Natl. Acad. Sci. USA 2010, 107(5):2001-2006.
83. Haldeman M.T., Xia G., Kasperek E.M., Pickart C.M. Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element. Biochemistry 1997, 36(34):10526-10537.
84. Handley P.M., Mueckler M., Siegel N.R., Ciechanover A., Schwartz A.L. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc. Natl. Acad. Sci. USA 1991, 88(1):258-262.
85. Hanpude P., Bhattacharya S., Dey A.K., Maiti T.K. Deubiquitinating enzymes in cellular signaling and disease regulation. IUBMB Life 2015, 67(7):544-555.
86. Hatakeyama S., Jensen J.P., Weissman A.M. Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases. J. Biol. Chem. 1997, 272(24):15085-15092.
87. Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K.I. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 2001, 276(35):33111-33120.
88. Helliwell S.B., Losko S., Kaiser C.A. Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. J. Cell Biol. 2001, 153(4):649-662.
89. Henderson J.M., Nisperos S.V., Weeks J., Ghulam M., Marín I., Zayas R.M. Identification of HECT E3 ubiquitin ligase family genes involved in stem cell regulation and regeneration in planarians. Dev. Biol. 2015, 404(2):21-34.
90. Herr R.A., Harris J., Fang S., Wang X., Hansen T.H. Role of the RING-CH domain of viral ligase mK3 in ubiquitination of non-lysine and lysine MHC I residues. Traffic 2009, 10(9):1301-1317.
91. Herrmann J., Lerman L.O., Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 2007, 100(9):1276-1291.
92. Hershko A. Ubiquitin-mediated protein degradation. J. Biol. Chem. 1988, 263(30):15237-15240.
93. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
94. Hershko A., Ciechanover A., Heller H., Haas A.L., Rose I.A. Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc. Natl. Acad. Sci. USA 1980, 77(4):1783-1786.
95. Hershko A., Ciechanover A., Rose I.A. Identification of the active amino acid residue of the polypeptide of ATP-dependent protein breakdown. J. Biol. Chem. 1981, 256(4):1525-1528.
96. Hershko A., Heller H., Elias S., Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J. Biol. Chem. 1983, 258(13):8206-8214.
97. Hershko A., Heller H., Eytan E., Reiss Y. The protein substrate binding site of the ubiquitin-protein ligase system. J. Biol. Chem. 1986, 261(26):11992-11999.
98. Hershko A., Leshinsky E., Ganoth D., Heller H. ATP-dependent degradation of ubiquitin-protein conjugates. Proc. Natl. Acad. Sci. USA 1984, 81(6):1619-1623.
99. Hershko A., Tomkins G.M. Studies on the degradation of tyrosine aminotransferase in hepatoma cells in culture. Influence of the composition of the medium and adenosine triphosphate dependence. J. Biol. Chem. 1971, 246(3):710-714.
100. Hindley C.J., McDowell G.S., Wise H., Philpott A. Regulation of cell fate determination by Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases. Int. J. Dev. Biol. 2011, 55(3):249-260.
101. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009, 458(7237):422-429.
102. Hock A.K., Vousden K.H. The role of ubiquitin modification in the regulation of p53. Biochim. Biophys. Acta 2014, 1843(1):137-149.
103. Hofmann R.M., Pickart C.M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 1999, 96(5):645-653.
104. Hogness D.S., Cohn M., Monod J. Studies on the induced synthesis of beta-galactosidase in Escherichia coli: the kinetics and mechanism of sulfur incorporation. Biochim. Biophys. Acta 1955, 16(1):99-116.
105. Hong J., Zhou J., Fu J., He T., Qin J., Wang L., Liao L., Xu J. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011, 71(11):3980-3990.
106. Hong J.H., Ng D., Srikumar T., Raught B. The use of ubiquitin lysine mutants to characterize E2-E3 linkage specificity: mass spectrometry offers a cautionary "tail". Proteomics 2015, 15(17):2910-2915.
107. Hoppe T. Multiubiquitylation by E4 enzymes: "one size" doesn't fit all. Trends Biochem. Sci. 2005, 30(4):183-187.
108. Hospenthal M.K., Mevissen T.E., Komander D. Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest). Nat. Protoc. 2015, 10(2):349-361.
109. Huang Y., Minaker S., Roth C., Huang S., Hieter P., Lipka V., Wiermer M., Li X. An E4 ligase facilitates polyubiquitination of plant immune receptor resistance proteins in Arabidopsis. Plant Cell 2014, 26(1):485-496.
110. Huber A.H., Stewart D.B., Laurents D.V., Nelson W.J., Weis W.I. The cadherin cytoplasmic domain is unstructured in the absence of beta-catenin. A possible mechanism for regulating cadherin turnover. J. Biol. Chem. 2001, 276(15):12301-12309.
111. Huibregtse J.M., Scheffner M., Beaudenon S., Howley P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 1995, 92(7):2563-2567.
112. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 2007, 28(5):730-738.
113. Hwang J., Winkler L., Kalejta R.F. Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim. Biophys. Acta 2011, 1816(2):147-157.
114. Ikeda M., Ikeda A., Longnecker R. Lysine-Independent Ubiquitination of Epstein-Barr Virus LMP2A. Virology 2002, 300(1):153-159. Available from: http://ac.els-cdn.com/S004268220291562X/1-s2.0-S004268220291562X-main.pdf?_tid=1097186e-3939-11e5-afa5-00000aab0f01&acdnat=1438535475_b72750ea7bcbfcccb366356968f4e176.
115. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 2002, 10(1):55-67.
116. Inobe T., Fishbain S., Prakash S., Matouschek A. Defining the geometry of the two-component proteasome degron. Nat. Chem. Biol. 2011, 7(3):161-167.
117. Ishikura S., Weissman A.M., Bonifacino J.S. Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J. Biol. Chem. 2010, 285(31):23916-23924.
118. Jackson P.K., Eldridge A.G., Freed E., Furstenthal L., Hsu J.Y., Kaiser B.K., Reimann J.D. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 2000, 10(10):429-439.
119. Jariel-Encontre I., Bossis G., Piechaczyk M. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 2008, 1786(2):153-177.
120. Jenny M., Uhl C., Roche C., Duluc I., Guillermin V., Guillemot F., Jensen J., Kedinger M., Gradwohl G. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 2002, 21(23):6338-6347.
121. Jin J., Li X., Gygi S.P., Harper J.W. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 2007, 447(7148):1135-1138.
122. Johansson K.A., Dursun U., Jordan N., Gu G., Beermann F., Gradwohl G., Grapin-Botton A. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev. Cell 2007, 12(3):457-465.
123. Johnson E.S., Ma P.C., Ota I.M., Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 1995, 270(29):17442-17456.
124. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
125. Kessler B.M. Ubiquitin-omics reveals novel networks and associations with human disease. Curr. Opin. Chem. Biol. 2013, 17(1):59-65.
126. King R.W., Glotzer M., Kirschner M.W. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol. Biol. Cell 1996, 7(9):1343-1357.
127. King R.W., Peters J.M., Tugendreich S., Rolfe M., Hieter P., Kirschner M.W. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 1995, 81(2):279-288.
128. Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., Iwai K. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 2006, 25(20):4877-4887. Available from: http://emboj.embopress.org/content/embojnl/25/20/4877.full.pdf.
129. Kitzmann M., Vandromme M., Schaeffer V., Carnac G., Labbé J.C., Lamb N., Fernandez A. cdk1-and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell. Biol. 1999, 19(4):3167-3176.
130. Klemperer N.S., Berleth E.S., Pickart C.M. A novel, arsenite-sensitive E2 of the ubiquitin pathway: purification and properties. Biochemistry 1989, 28(14):6035-6041.
131. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96(5):635-644.
132. Komander D. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 2009, 37(Pt 5):937-953.
133. Komander D. Mechanism, specificity and structure of the deubiquitinases. Subcell. Biochem. 2010, 54:69-87.
134. Komander D., Barford D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 2008, 409(1):77-85.
135. Komander D., Clague M.J., Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10(8):550-563.
136. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
137. Kragt A., Voorn-Brouwer T., van den Berg M., Distel B. The Saccharomyces cerevisiae peroxisomal import receptor Pex5p is monoubiquitinated in wild type cells. J. Biol. Chem. 2005, 280(9):7867-7874.
138. Kravtsova-Ivantsiv Y., Ciechanover A. Non-canonical ubiquitin-based signals for proteasomal degradation. J. Cell Sci. 2012, 125(Pt 3):539-548.
139. Kriwacki R.W., Hengst L., Tennant L., Reed S.I., Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA 1996, 93(21):11504-11509.
140. Kulathu Y., Komander D. Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell Biol. 2012, 13(8):508-523.
141. Kuo M.L., den Besten W., Bertwistle D., Roussel M.F., Sherr C.J. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 2004, 18(15):1862-1874.
142. Lai Z., Ferry K.V., Diamond M.A., Wee K.E., Kim Y.B., Ma J., Yang T., Benfield P.A., Copeland R.A., Auger K.R. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 2001, 276(33):31357-31367.
143. Lee J.H., Elly C., Park Y., Liu Y.C. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1α to maintain regulatory T cell stability and suppressive capacity. Immunity 2015, 42(6):1062-1074.
144. Léon S., Subramani S. A conserved cysteine residue of Pichia pastoris Pex20p is essential for its recycling from the peroxisome to the cytosol. J. Biol. Chem. 2007, 282(10):7424-7430.
145. Li H., Okamoto K., Peart M.J., Prives C. Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A. Mol. Cell. Biol. 2009, 29(3):919-928.
146. Li M., Zhang P. The function of APC/CCdh1 in cell cycle and beyond. Cell Div. 2009, 4:2.
147. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 1999, 96(20):11364-11369.
148. Love I.M., Shi D., Grossman S.R. p53 Ubiquitination and proteasomal degradation. Methods Mol. Biol. 2013, 962:63-73.
149. Lu S., Nie J., Luan Q., Feng Q., Xiao Q., Chang Z., Shan C., Hess D., Hemmings B.A., Yang Z. Phosphorylation of the Twist1-family basic helix-loop-helix transcription factors is involved in pathological cardiac remodeling. PLoS ONE 2011, 6(4):e19251.
150. Lu Y., Lee B.H., King R.W., Finley D., Kirschner M.W. Substrate degradation by the proteasome: a single-molecule kinetic analysis. Science 2015, 348(6231):1250834.
151. Machiya Y., Hara S., Arawaka S., Fukushima S., Sato H., Sakamoto M., Koyama S., Kato T. Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner. J. Biol. Chem. 2010, 285(52):40732-40744.
152. Magadán J.G., Pérez-Victoria F.J., Sougrat R., Ye Y., Strebel K., Bonifacino J.S. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6(4):e1000869.
153. Manchado E., Eguren M., Malumbres M. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. Biochem. Soc. Trans. 2010, 38(Pt 1):65-71.
154. Mao D.D., Gujar A.D., Mahlokozera T., Chen I., Pan Y., Luo J., Brost T., Thompson E.A., Turski A., Leuthardt E.C., Dunn G.P., Chicoine M.R., Rich K.M., Dowling J.L., Zipfel G.J., Dacey R.G., Achilefu S., Tran D.D., Yano H., Kim A.H. A CDC20-APC/SOX2 signaling axis regulates human glioblastoma stem-like cells. Cell Rep. 2015, 11(11):1809-1821.
155. Marino S.M., Gladyshev V.N. Analysis and functional prediction of reactive cysteine residues. J. Biol. Chem. 2012, 287(7):4419-4425.
156. Markson G., Kiel C., Hyde R., Brown S., Charalabous P., Bremm A., Semple J., Woodsmith J., Duley S., Salehi-Ashtiani K., Vidal M., Komander D., Serrano L., Lehner P., Sanderson C.M. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res. 2009, 19(10):1905-1911.
157. Mastrandrea L.D., Kasperek E.M., Niles E.G., Pickart C.M. Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K. Biochemistry 1998, 37(27):9784-9792.
158. Matsumoto M., Yada M., Hatakeyama S., Ishimoto H., Tanimura T., Tsuji S., Kakizuka A., Kitagawa M., Nakayama K.I. Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J. 2004, 23(3):659-669.
159. Matsumoto M.L., Wickliffe K.E., Dong K.C., Yu C., Bosanac I., Bustos D., Phu L., Kirkpatrick D.S., Hymowitz S.G., Rape M., Kelley R.F., Dixit V.M. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 2010, 39(3):477-484.
160. McClurg U.L., Robson C.N. Deubiquitinating enzymes as oncotargets. Oncotarget 2015, 6(12):9657-9668.
161. McDowell G.S., Gaun A., Steen H. iFASP: combining isobaric mass tagging with filter-aided sample preparation. J. Proteome Res. 2013, 12(8):3809-3812.
162. McDowell G.S., Hardwick L.J., Philpott A. Complex domain interactions regulate stability and activity of closely related proneural transcription factors. Biochem. Biophys. Res. Commun. 2014, 450(4):1283-1290.
163. McDowell G.S., Hindley C.J., Lippens G., Landrieu I., Philpott A. Phosphorylation in intrinsically disordered regions regulates the activity of Neurogenin2. BMC Biochem. 2014, 15(1):24.
164. McDowell G.S., Kucerova R., Philpott A. Non-canonical ubiquitylation of the proneural protein Ngn2 occurs in both Xenopus embryos and mammalian cells. Biochem. Biophys. Res. Commun. 2010, 400(4):655-660.
165. McDowell G.S., Philpott A. Non-canonical ubiquitylation: mechanisms and consequences. Int. J. Biochem. Cell Biol. 2013, 45(8):1833-1842.
166. Meek D.W. Regulation of the p53 response and its relationship to cancer. Biochem. J. 2015, 469(3):325-346.
167. Metzger M.B., Hristova V.A., Weissman A.M. HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 2012, 125(Pt 3):531-537.
168. Metzger M.B., Pruneda J.N., Klevit R.E., Weissman A.M. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim. Biophys. Acta 2014, 1843(1):47-60.
169. Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M., Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F., Freund S.M., Ovaa H., Komander D. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013, 154(1):169-184.
170. Meyer H.J., Rape M. Enhanced protein degradation by branched ubiquitin chains. Cell 2014, 157(4):910-921.
171. Monia B.P., Ecker D.J., Jonnalagadda S., Marsh J., Gotlib L., Butt T.R., Crooke S.T. Gene synthesis, expression, and processing of human ubiquitin carboxyl extension proteins. J. Biol. Chem. 1989, 264(7):4093-4103.
172. Mortensen F., Schneider D., Barbic T., Sladewska-Marquardt A., Kühnle S., Marx A., Scheffner M. Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination. Proc. Natl. Acad. Sci. USA 2015, 112(32):9872-9877.
173. Na C.H., Peng J. Analysis of ubiquitinated proteome by quantitative mass spectrometry. Methods Mol. Biol. 2012, 893:417-429.
174. Nash P., Tang X., Orlicky S., Chen Q., Gertler F.B., Mendenhall M.D., Sicheri F., Pawson T., Tyers M. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 2001, 414(6863):514-521.
175. Naujokat C., Sarić T. Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells. Stem Cells 2007, 25(10):2408-2418.
176. Ndubaku C., Tsui V. Inhibiting the Deubiquitinating Enzymes (DUBs). J. Med. Chem. 2014, 58(4):1581-1595.
177. Nguyen L.K. Dynamics of ubiquitin-mediated signalling: insights from mathematical modelling and experimental studies. Brief Bioinform. 2015, 16:1-15.
178. Nguyen L.K., Dobrzyński M., Fey D., Kholodenko B.N. Polyubiquitin chain assembly and organization determine the dynamics of protein activation and degradation. Front Physiol. 2014, 5:4. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901042/pdf/fphys-05-00004.pdf.
179. Noy T., Suad O., Taglicht D., Ciechanover A. HUWE1 ubiquitinates MyoD and targets it for proteasomal degradation. Biochem. Biophys. Res. Commun. 2012, 418(2):408-413.
180. Ostapenko D., Burton J.L., Solomon M.J. The Ubp15 deubiquitinase promotes timely entry into S phase in Saccharomyces cerevisiae. Mol. Biol. Cell 2015, 26(12):2205-2216.
181. Palmiter R.D. Prevention of NH2-terminal acetylation of proteins synthesized in cell-free systems. J. Biol. Chem. 1977, 252(24):8781-8783.
182. Papaleo E., Ranzani V., Tripodi F., Vitriolo A., Cirulli C., Fantucci P., Alberghina L., Vanoni M., De Gioia L., Coccetti P. An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in Cdc34-like enzymes. PLoS Comput. Biol. 2011, 7(5):e1002056.
183. Pelzer C., Kassner I., Matentzoglu K., Singh R.K., Wollscheid H.P., Scheffner M., Schmidtke G., Groettrup M. UBE1L2, a novel E1 enzyme specific for ubiquitin. J. Biol. Chem. 2007, 282(32):23010-23014.
184. Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003, 21(8):921-926. Available from: http://www.nature.com/nbt/journal/v21/n8/full/nbt849.html.
185. Pereira R.V., de Souza Gomes M., Costa M.P., Jannotti Passos L.K., de Castro Borges W., Guerra-Sá R. MJD and OTU deubiquitinating enzymes in Schistosoma mansoni. Parasitol. Res. 2015, 114(8):2835-2843.
186. Peters J.M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 2006, 7(9):644-656.
187. Petroski M.D., Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6(1):9-20.
188. Petroski M.D., Deshaies R.J. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell 2005, 123(6):1107-1120.
189. Pichler A., Knipscheer P., Oberhofer E., van Dijk W.J., Körner R., Olsen J.V., Jentsch S., Melchior F., Sixma T.K. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 2005, 12(3):264-269.
190. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 2001, 70:503-533.
191. Pickart C.M., Cohen R.E. Proteasomes and their kin: proteases in the machine age. Nat. Rev. Mol. Cell Biol. 2004, 5(3):177-187.
192. Pickart C.M., Fushman D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 2004, 8(6):610-616.
193. Pines J. Cubism and the cell cycle: the many faces of the APC/C. Nat. Rev. Mol. Cell Biol. 2011, 12(7):427-438.
194. Plaxco K.W., Simons K.T., Baker D. Contact order, transition state placement and the refolding rates of single domain proteins. J. Mol. Biol. 1998, 277(4):985-994.
195. Polevoda B., Sherman F. Nalpha-terminal acetylation of eukaryotic proteins. J. Biol. Chem. 2000, 275(47):36479-36482.
196. Polevoda B., Sherman F. The diversity of acetylated proteins. Genome Biol. 2002, 3(5). 1-reviews0006.6.
197. Polevoda B., Sherman F. Composition and function of the eukaryotic N-terminal acetyltransferase subunits. Biochem. Biophys. Res. Commun. 2003, 308(1):1-11.
198. Polevoda B., Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J. Mol. Biol. 2003, 325(4):595-622.
199. Poulsen E.G., Steinhauer C., Lees M., Lauridsen A.M., Ellgaard L., Hartmann-Petersen R. HUWE1 and TRIP12 collaborate in degradation of ubiquitin-fusion proteins and misframed ubiquitin. PLoS ONE 2012, 7(11):e50548.
200. Prakash S., Inobe T., Hatch A.J., Matouschek A. Substrate selection by the proteasome during degradation of protein complexes. Nat. Chem. Biol. 2009, 5(1):29-36.
201. Prakash S., Tian L., Ratliff K.S., Lehotzky R.E., Matouschek A. An unstructured initiation site is required for efficient proteasome-mediated degradation. Nat. Struct. Mol. Biol. 2004, 11(9):830-837.
202. Primorac I., Musacchio A. Panta rhei: the APC/C at steady state. J. Cell Biol. 2013, 201(2):177-189.
203. Puig-Sàrries P., Bijlmakers M.J., Zuin A., Bichmann A., Pons M., Crosas B. An intrinsically disordered region of RPN10 plays a key role in restricting ubiquitin chain elongation in RPN10 monoubiquitination. Biochem. J. 2015, 469(3):455-467.
204. Rawlings N., Barrett A. Families of serine peptidases. Proteolytic Enzymes: Serine and Cysteine Peptidases 1994, Academic Press, pp. 19-61 (Chapter 2).
205. Reed B.J., Locke M.N., Gardner R.G. A conserved deubiquitinating enzyme uses intrinsically disordered regions to scaffold multiple protein-interaction sites. J. Biol. Chem. 2015, 290(33):20601-20612.
206. Reinstein E., Scheffner M., Oren M., Ciechanover A., Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 2000, 19(51):5944-5950. Available from: http://www.nature.com.ezproxy.library.tufts.edu/onc/journal/v19/n51/pdf/1203989a.pdf.
207. Richly H., Rape M., Braun S., Rumpf S., Hoege C., Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 2005, 120(1):73-84.
208. Roark R., Itzhaki L., Philpott A. Complex regulation controls Neurogenin3 proteolysis. Biol. Open 2012, 1(12):1264-1272.
209. Rodrigo-Brenni M.C., Morgan D.O. Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell 2007, 130(1):127-139.
210. Sadeh R., Breitschopf K., Bercovich B., Zoabi M., Kravtsova-Ivantsiv Y., Kornitzer D., Schwartz A., Ciechanover A. The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proc. Natl. Acad. Sci. USA 2008, 105(41):15690-15695.
211. Sadowski M., Suryadinata R., Lai X., Heierhorst J., Sarcevic B. Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34. Mol. Cell. Biol. 2010, 30(10):2316-2329.
212. Sahtoe D.D., Sixma T.K. Layers of DUB regulation. Trends Biochem. Sci. 2015, 40:456-467.
213. Santonico E., Mattioni A., Panni S., Belleudi F., Mattei M., Torrisi M.R., Cesareni G., Castagnoli L. RNF11 is a GGA protein cargo and acts as a molecular adaptor for GGA3 ubiquitination mediated by Itch. Oncogene 2015, 34(26):3377-3390.
214. Scaglione K.M., Basrur V., Ashraf N.S., Konen J.R., Elenitoba-Johnson K.S., Todi S.V., Paulson H.L. The ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N terminus of substrates. J. Biol. Chem. 2013, 288(26):18784-18788.
215. Scaglione K.M., Zavodszky E., Todi S.V., Patury S., Xu P., Rodríguez-Lebrón E., Fischer S., Konen J., Djarmati A., Peng J., Gestwicki J.E., Paulson H.L. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 2011, 43(4):599-612.
216. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75(3):495-505.
217. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995, 373(6509):81-83.
218. Schimke R.T., Doyle D. Control of enzyme levels in animal tissues. Annu. Rev. Biochem. 1970, 39:929-976.
219. Schoenheimer R. The Dynamic State of Body Constituents 1942, Harvard University Press, Cambridge, MA.
220. Schoenheimer R., Ratner S., Rittenberg D. The process of continuous deamination and reamination of amino acids in the proteins of normal animals. Science 1939, 89(2308):272-273.
221. Schrader E.K., Harstad K.G., Matouschek A. Targeting proteins for degradation. Nat. Chem. Biol. 2009, 5(11):815-822.
222. Schulman B.A., Harper J.W. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 2009, 10(5):319-331.
223. Schwartzkopff B., Platta H.W., Girzalsky W., Erdmann R. Cysteine-specific ubiquitination protects the peroxisomal import receptor Pex5p against proteasomal degradation. Biosci. Rep. 2015, 35(3):e00215.
224. Schwitzgebel V.M., Scheel D.W., Conners J.R., Kalamaras J., Lee J.E., Anderson D.J., Sussel L., Johnson J.D., German M.S. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000, 127(16):3533-3542.
225. Scott K.A., Randles L.G., Moran S.J., Daggett V., Clarke J. The folding pathway of spectrin R17 from experiment and simulation: using experimentally validated MD simulations to characterize States hinted at by experiment. J. Mol. Biol. 2006, 359(1):159-173.
226. Semple C.A. The comparative proteomics of ubiquitination in mouse. Genome Res. 2003, 13(6B):1389-1394.
227. Serang O., Froehlich J.W., Muntel J., McDowell G., Steen H., Lee R.S., Steen J.A. SweetSEQer, simple de novo filtering and annotation of glycoconjugate mass spectra. Mol. Cell. Proteomics 2013, 12(6):1735-1740.
228. Serang O., Noble W. A review of statistical methods for protein identification using tandem mass spectrometry. Stat. Interface 2012, 5(1):3-20.
229. Shi D., Pop M.S., Kulikov R., Love I.M., Kung A.L., Kung A., Grossman S.R. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc. Natl. Acad. Sci. USA 2009, 106(38):16275-16280.
230. Shimizu Y., Okuda-Shimizu Y., Hendershot L.M. Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Mol. Cell 2010, 40(6):917-926.
231. Shimura H., Hattori N., Kubo S.I., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000, 25(3):302-305.
232. Simpson M.V. The release of labeled amino acids from the proteins of rat liver slices. J. Biol. Chem. 1953, 201(1):143-154.
233. Sivakumar S., Gorbsky G.J. Spatiotemporal regulation of the anaphase-promoting complex in mitosis. Nat. Rev. Mol. Cell Biol. 2015, 16(2):82-94.
234. Song A., Wang Q., Goebl M.G., Harrington M.A. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 1998, 18(9):4994-4999.
235. Song J., Wang J., Jozwiak A.A., Hu W., Swiderski P.M., Chen Y. Stability of thioester intermediates in ubiquitin-like modifications. Protein Sci. 2009, 18(12):2492-2499.
236. Song L., Rape M. Substrate-specific regulation of ubiquitination by the anaphase-promoting complex. Cell Cycle 2011, 10(1):52-56.
237. Srivastava D., Chakrabarti O. Ubiquitin in regulation of spindle apparatus and its positioning: implications in development and disease. Biochem. Cell Biol. 2015, 93:273-281.
238. Stacey K.B., Breen E., Jefferies C.A. Tyrosine phosphorylation of the E3 ubiquitin ligase TRIM21 positively regulates interaction with IRF3 and hence TRIM21 activity. PLoS ONE 2012, 7(3):e34041.
239. Steward A., McDowell G.S., Clarke J. Topology is the principal determinant in the folding of a complex all-alpha Greek key death domain from human FADD. J. Mol. Biol. 2009, 389(2):425-437.
240. Stieglitz B., Morris-Davies A.C., Koliopoulos M.G., Christodoulou E., Rittinger K. LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep. 2012, 13(9):840-846.
241. Sudakin V., Ganoth D., Dahan A., Heller H., Hershko J., Luca F.C., Ruderman J.V., Hershko A. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 1995, 6(2):185-197. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC275828/pdf/mbc00022-0059.pdf.
242. Sylvestersen K.B., Young C., Nielsen M.L. Advances in characterizing ubiquitylation sites by mass spectrometry. Curr. Opin. Chem. Biol. 2013, 17(1):49-58.
243. Tait S.W., de Vries E., Maas C., Keller A.M., D'Santos C.S., Borst J. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 2007, 179(7):1453-1466.
244. Takahashi K., Matouschek A., Inobe T. Regulation of proteasomal degradation by modulating proteasomal initiation regions. ACS Chem. Biol. 2015, 10(11):2537-2543. Available from: http://pubs.acs.org/doi/abs/10.1021/acschembio.5b00554.
245. Tarrant M.K., Cole P.A. The chemical biology of protein phosphorylation. Annu. Rev. Biochem. 2009, 78:797-825.
246. Tatham M.H., Plechanovová A., Jaffray E.G., Salmen H., Hay R.T. Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. Biochem. J. 2013, 453(1):137-145. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778709/pdf/bj4530137.pdf.
247. Tedesco D., Lukas J., Reed S.I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 2002, 16(22):2946-2957.
248. Thayer M.J., Tapscott S.J., Davis R.L., Wright W.E., Lassar A.B., Weintraub H. Positive autoregulation of the myogenic determination gene MyoD1. Cell 1989, 58(2):241-248.
249. Thrower J.S., Hoffman L., Rechsteiner M., Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19(1):94-102.
250. Tintignac L.A., Leibovitch M.P., Kitzmann M., Fernandez A., Ducommun B., Meijer L., Leibovitch S.A. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp. Cell Res. 2000, 259(1):300-307.
251. Tobias J.W., Varshavsky A. Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae. J. Biol. Chem. 1991, 266(18):12021-12028.
252. Tokarev A.A., Munguia J., Guatelli J.C. Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J. Virol. 2011, 85(1):51-63.
253. Tokmakov A.A., Kurotani A., Ikeda M., Terazawa Y., Shirouzu M., Stefanov V., Sakurai T., Yokoyama S. Content of intrinsic disorder influences the outcome of cell-free protein synthesis. Sci. Rep. 2015, 5:14079.
254. Townsend K., Mason H., Blackford A.N., Miller E.S., Chapman J.R., Sedgwick G.G., Barone G., Turnell A.S., Stewart G.S. Mediator of DNA damage checkpoint 1 (MDC1) regulates mitotic progression. J. Biol. Chem. 2009, 284(49):33939-33948.
255. Trausch-Azar J., Leone T.C., Kelly D.P., Schwartz A.L. Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1 via the N-terminal pathway. J. Biol. Chem. 2010, 285(51):40192-40200.
256. Trausch-Azar J.S., Lingbeck J., Ciechanover A., Schwartz A.L. Ubiquitin-proteasome-mediated degradation of Id1 is modulated by MyoD. J. Biol. Chem. 2004, 279(31):32614-32619.
257. Treier M., Staszewski L.M., Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 1994, 78(5):787-798.
258. Truong K., Su Y., Song J., Chen Y. Entropy-driven mechanism of an E3 ligase. Biochemistry 2011, 50(25):5757-5766.
259. Uhler J.P., Spåhr H., Farge G., Clavel S., Larsson N.G., Falkenberg M., Samuelsson T., Gustafsson C.M. The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. Biochem. Biophys. Res. Commun. 2014, 443(1):7-12.
260. Van der Lee R., Lang B., Kruse K., Gsponer J., Sánchez de Groot N., Huynen M.A., Matouschek A., Fuxreiter M., Babu M.M. Intrinsically disordered segments affect protein half-life in the cell and during evolution. Cell Rep. 2014, 8(6):1832-1844.
261. Van der Veen A.G., Ploegh H.L. Ubiquitin-like proteins. Annu. Rev. Biochem. 2012, 81:323-357.
262. Van Leuken R., Clijsters L., Wolthuis R. To cell cycle, swing the APC/C. Biochim. Biophys. Acta 2008, 1786(1):49-59.
263. Van Wijk S.J., Timmers H.T. The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J. 2010, 24(4):981-993.
264. Varland S., Osberg C., Arnesen T. N-terminal modifications of cellular proteins: the enzymes involved, their substrate specificities and biological effects. Proteomics 2015, 15(14):2385-2401.
265. Varshavsky A. The ubiquitin system. Trends Biochem. Sci. 1997, 22(10):383-387.
266. Varshavsky A. The N-end rule pathway and regulation by proteolysis. Protein Sci. 2011, 20(8):1298-1345.
267. Varshavsky A. The ubiquitin system, an immense realm. Annu. Rev. Biochem. 2012, 81:167-176.
268. Verma R., Aravind L., Oania R., McDonald W.H., Yates J.R., Koonin E.V., Deshaies R.J. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298(5593):611-615.
269. Visintin R., Prinz S., Amon A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 1997, 278(5337):460-463.
270. Vittal V., Shi L., Wenzel D.M., Scaglione K.M., Duncan E.D., Basrur V., Elenitoba-Johnson K.S., Baker D., Paulson H.L., Brzovic P.S., Klevit R.E. Intrinsic disorder drives N-terminal ubiquitination by Ube2w. Nat. Chem. Biol. 2015, 11(1):83-89.
271. Vittal V., Stewart M.D., Brzovic P.S., Klevit R.E. Regulating the regulators: recent revelations in the control of E3 ubiquitin ligases. J. Biol. Chem. 2015, 290(35):21244-21251.
272. Vosper J.M., Fiore-Heriche C.S., Horan I., Wilson K., Wise H., Philpott A. Regulation of neurogenin stability by ubiquitin-mediated proteolysis. Biochem. J. 2007, 407(2):277-284.
273. Vosper J.M., McDowell G.S., Hindley C.J., Fiore-Heriche C.S., Kucerova R., Horan I., Philpott A. Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis. J. Biol. Chem. 2009, 284(23):15458-15468.
274. Wang K.H., Roman-Hernandez G., Grant R.A., Sauer R.T., Baker T.A. The molecular basis of N-end rule recognition. Mol. Cell 2008, 32(3):406-414.
275. Wang X., Connors R., Harris M.R., Hansen T.H., Lybarger L. Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3. J. Virol. 2005, 79(7):4099-4108.
276. Wang X., Herr R.A., Chua W.J., Lybarger L., Wiertz E.J., Hansen T.H. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 2007, 177(4):613-624.
277. Wang Y., Ha S.W., Zhang T., Kho D.H., Raz A., Xie Y. Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases. Oncotarget 2014, 5(8):2044-2051.
278. Wang Y., Shao Q., Yu X., Kong W., Hildreth J.E., Liu B. N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination. J. Virol. 2011, 85(9):4510-4519.
279. Wang Y., Yang J., Yi J. Redox sensing by proteins: oxidative modifications on cysteines and the consequent events. Antioxid. Redox Signal. 2012, 16(7):649-657.
280. Wauer T., Simicek M., Schubert A., Komander D. Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature 2015, 524(7565):370-374.
281. Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N., Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D. Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J. 2015, 34(3):307-325.
282. Wei R., Liu X., Yu W., Yang T., Cai W., Liu J., Huang X., Xu G.T., Zhao S., Yang J., Liu S. Deubiquitinases in cancer. Oncotarget 2015, 6(15):12872-12889. Available from: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=3671.
283. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2001, 2(3):169-178.
284. Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474(7349):105-108.
285. Wickliffe K.E., Lorenz S., Wemmer D.E., Kuriyan J., Rape M. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 2011, 144(5):769-781.
286. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 1997, 11(14):1245-1256.
287. Wilkinson K.D., Urban M.K., Haas A.L. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 1980, 255(16):7529-7532.
288. Willems A.R., Schwab M., Tyers M. A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. Biophys. Acta 2004, 1695(1-3):133-170.
289. Williams C., van den Berg M., Sprenger R.R., Distel B. A conserved cysteine is essential for Pex4p-dependent ubiquitination of the peroxisomal import receptor Pex5p. J. Biol. Chem. 2007, 282(31):22534-22543.
290. Winston J.T., Strack P., Beer-Romero P., Chu C.Y., Elledge S.J., Harper J.W. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999, 13(3):270-283.
291. Wu H., Leng R.P. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation. Cell Cycle 2011, 10(12):1912-1915.
292. Wu H., Pomeroy S.L., Ferreira M., Teider N., Mariani J., Nakayama K.I., Hatakeyama S., Tron V.A., Saltibus L.F., Spyracopoulos L., Leng R.P. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat. Med. 2011, 17(3):347-355.
293. Wu P.Y., Hanlon M., Eddins M., Tsui C., Rogers R.S., Jensen J.P., Matunis M.J., Weissman A.M., Weisman A.M., Weissman A.M., Wolberger C., Wolberger C.P., Pickart C.M. A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J. 2003, 22(19):5241-5250.
294. Xie L., Lang-Mladek C., Richter J., Nigam N., Hauser M.T. UV-B induction of the E3 ligase ARIADNE12 depends on CONSTITUTIVELY PHOTOMORPHOGENIC 1. Plant Physiol. Biochem. 2015, 93:18-28.
295. Xie Q., Wu Q., Mack S.C., Yang K., Kim L., Hubert C.G., Flavahan W.A., Chu C., Bao S., Rich J.N. CDC20 maintains tumor initiating cells. Oncotarget 2015, 6(15):13241-13254.
296. Xu G., Deglincerti A., Paige J.S., Jaffrey S.R. Profiling lysine ubiquitination by selective enrichment of ubiquitin remnant-containing peptides. Methods Mol. Biol. 2014, 1174:57-71.
297. Xu P., Duong D.M., Seyfried N.T., Cheng D., Xie Y., Robert J., Rush J., Hochstrasser M., Finley D., Peng J. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137(1):133-145.
298. Yan K., Li L., Wang X., Hong R., Zhang Y., Yang H., Lin M., Zhang S., He Q., Zheng D., Tang J., Yin Y., Shao G. The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells. J. Cell Biol. 2015, 210(2):209-224.
299. Yang J., Hong Y., Wang W., Wu W., Chi Y., Zong H., Kong X., Wei Y., Yun X., Cheng C., Chen K., Gu J. HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation. FEBS Lett. 2009, 583(9):1409-1414.
300. Yang X., Brownell J.E., Xu Q., Zhu F., Ma J., Loke H.K., Rollins N., Soucy T.A., Minissale J.J., Thomas M.P., Mallender W.D., Dick L.R., Li P., Liao H. Absolute quantification of E1, ubiquitin-like proteins and Nedd8-MLN4924 adduct by mass spectrometry. Cell Biochem. Biophys. 2013, 67(1):139-147.
301. Yang Y., Kitagaki J., Dai R.M., Tsai Y.C., Lorick K.L., Ludwig R.L., Pierre S.A., Jensen J.P., Davydov I.V., Oberoi P., Li C.C., Kenten J.H., Beutler J.A., Vousden K.H., Weissman A.M. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 2007, 67(19):9472-9481.
302. Ye Y., Blaser G., Horrocks M.H., Ruedas-Rama M.J., Ibrahim S., Zhukov A.A., Orte A., Klenerman D., Jackson S.E., Komander D. Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 2012, 492(7428):266-270.
303. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10(11):755-764.
304. Yi J.J., Berrios J., Newbern J.M., Snider W.D., Philpot B.D., Hahn K.M., Zylka M.J. An autism-linked mutation disables phosphorylation control of UBE3A. Cell 2015, 162(4):795-807.
305. Yunus A.A., Lima C.D. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway. Nat. Struct. Mol. Biol. 2006, 13(6):491-499.
306. Zarrine-Afsar A., Larson S.M., Davidson A.R. The family feud: do proteins with similar structures fold via the same pathway?. Curr. Opin. Struct. Biol. 2005, 15(1):42-49.
307. Zhang N.Y., Jacobson A.D., Macfadden A., Liu C.W. Ubiquitin chain trimming recycles the substrate binding sites of the 26 S proteasome and promotes degradation of lysine 48-linked polyubiquitin conjugates. J. Biol. Chem. 2011, 286(29):25540-25546.
308. Zhang X., Wang Y. Cell cycle regulation of VCIP135 deubiquitinase activity and function in p97/p47-mediated Golgi reassembly. Mol. Biol. Cell 2015, 26(12):2242-2251.
309. Zhang X.F., Pan Q.Z., Pan K., Weng D.S., Wang Q.J., Zhao J.J., He J., Liu Q., Wang D.D., Jiang S.S., Zheng H.X., Lv L., Chen C.L., Zhang H.X., Xia J.C. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma. Mol. Carcinog. 2015, 55(1):64-76.
310. Zou H., McGarry T.J., Bernal T., Kirschner M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999, 285(5426):418-422.